Giuseppe Saglio, MD, University of Turin, Turin, Italy, shares some of the key points shared at the Michele Baccarani Symposium that took place at this year’s ESH CML meeting, commenting on the impact of mutations on disease resistance and progression. This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.